Special Issue "Antimicrobial Peptides for Therapeutic Applications"
A special issue of Biologics (ISSN 2673-8449).
Deadline for manuscript submissions: closed (1 May 2023) | Viewed by 3725
Special Issue Editor
Interests: antimicrobial peptides and inflammatory cells, in particular the preparation of cathelicidins–peptides with antimicrobial activity, their isolation from natural sources (blood from some species of animals, cell cultures), their purification using biochemical techniques (gel chromatography, MS MALDI-TOF), and characterization of their properties, especially their influence on inflammatory cells and regulation of inflammation and tissue repair; alternative means such as antimicrobial peptides and proteins, which can can be offered as possible replacement for antibiotics which have lost their effectiveness due to microbial resistance; antimicrobial peptides involved in the regulation of inflammation and the regenerative process in some tissues
Special Issue Information
Dear Collegues,
It is my pleasure to announce a new Special Issue entitled “Antimicrobial Peptides for Therapeutic Applications”, for which I am serving as Guest Editor and to which I sincerely invite you to contribute your research work based on your expertise.
Antimicrobial peptides, also known as host defense peptides, are a promising group of naturally derived or synthetic products composed of short peptides with antimicrobial and immunomodulatory properties with potential for different clinical applications, e.g., regenerative medicine.
This Special Issue of Biologics will cover new research in the area of antimicrobial peptides as biologics. The focus of this issue will be on the interactions of antimicrobial peptides with host cells and the mechanism of their multiple biological functions, as well as the methods for their characterization. Additionally, research on clinical and pre-clinical experiments involved in the application of antimicrobial peptides in human medicine and on animal models is warmly welcome. We particularly welcome original research papers and reviews on the potential use or clinical application of antimicrobial peptides in biomedical sciences. Manuscripts are due on 31 December 2022, but earlier submissions are welcome, and they will be processed upon receipt and published online upon acceptance.
Dr. Joanna Wessely-Szponder
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biologics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial peptides
- host defense peptides
- cathelicidins
- blood components
- tissue repair
- biologics
- immunomodulators
